These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 4005650

  • 1. The human pharmacology of silver sulphadiazine (AgSD).
    Fox CL.
    Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650
    [No Abstract] [Full Text] [Related]

  • 2. Topical silver sulphadiazine and profound neutropenia in a burned child.
    Wilson P, George R, Raine P.
    Burns Incl Therm Inj; 1986 Apr; 12(4):295-6. PubMed ID: 3719408
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Topical therapy and the development of silver sulfadiazine.
    Fox CL.
    Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475
    [Abstract] [Full Text] [Related]

  • 8. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM, Fox CL.
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
    Hoffmann S.
    Scand J Plast Reconstr Surg; 1984 Jul; 18(1):119-26. PubMed ID: 6377481
    [Abstract] [Full Text] [Related]

  • 12. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
    Modak S, Fox CL.
    J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
    [Abstract] [Full Text] [Related]

  • 13. Absorption, excretion and tissue distribution of silver sulphadiazine.
    Sano S, Fujimori R, Takashima M, Itokawa Y.
    Burns Incl Therm Inj; 1982 Mar; 8(4):278-85. PubMed ID: 7066727
    [Abstract] [Full Text] [Related]

  • 14. Systemic absorption of sulphadiazine, silver sulphadiazine and sodium sulphadiazine through human burn wounds.
    Aoyama H, Yokoo K, Fujii K.
    Burns; 1990 Jun; 16(3):163-5. PubMed ID: 2383353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacology and clinical use of silver sulfadiazine and related topical antimicrobial agents.
    Fox CL.
    Pahlavi Med J; 1977 Jan; 8(1):45-64. PubMed ID: 834468
    [Abstract] [Full Text] [Related]

  • 18. Topical chemotherapy for burns using cerium salts and silver sulfadiazine.
    Fox CL, Monafo WW, Ayvazian VH, Skinner AM, Modak S, Stanford J, Condict C.
    Surg Gynecol Obstet; 1977 May; 144(5):668-72. PubMed ID: 850849
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL, Rao TN, Azmeth R, Gandhi SS, Modak S.
    J Burn Care Rehabil; 1990 May; 11(2):112-7. PubMed ID: 2335547
    [Abstract] [Full Text] [Related]

  • 20. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE, Bevin AG, Steinkraus GE, Enterline DS.
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.